Fosfomycin for Pseudomonas-related exacerbations of cystic fibrosis

International Journal of Antimicrobial Agents

Volumn 32, Issue 5, 2008, Pages 461-463

  Faruqi, S ^a   McCreanor, J ^a   Moon, T ^a   Meigh, R ^a   Morice, A H ^a  

^a CASTLE HILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; FOSFOMYCIN; GENTAMICIN; IMIPENEM; LINEZOLID; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; VANCOMYCIN;

ABSENCE OF SIDE EFFECTS; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; CLINICAL ARTICLE; COUGHING; CYSTIC FIBROSIS; DISEASE EXACERBATION; DYSPNEA; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; LETTER; LUNG FUNCTION; LUNG INFECTION; MALE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; PRESCRIPTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TREATMENT DURATION;

ADULT; ANTI-BACTERIAL AGENTS; CYSTIC FIBROSIS; FEMALE; FOSFOMYCIN; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY FUNCTION TESTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 53249093710     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.05.010     Document Type: Letter

References (7)

1. Gibson R.L., Burns J.L., and Ramsey B.W. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 168 (2003) 918-951
2. Hendlin D., Stapley E.O., Jackson M., Wallick H., Miller A.K., Wolf F.J., et al. Phosphonomycin, a new antibiotic produced by strains of Streptomyces. Science 166 (1969) 122-123
3. Schülin T. In vitro activity of the aerosolized agents colistin and tobramycin and five intravenous agents against Pseudomonas aeruginosa isolated from cystic fibrosis patients in southwestern Germany. J Antimicrob Chemother 49 (2002) 403-406
4. Tessier F., and Quentin C. In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis 16 (1997) 159-162
5. Rodríguez-Martínez J.M., Ballesta S., and Pascual A. Activity and penetration of fosfomycin, ciprofloxacin, amoxicillin/clavulanic acid and co-trimoxazole in Escherichia coli and Pseudomonas aeruginosa biofilms. Int J Antimicrob Agents 30 (2007) 366-368
6. Mirakhur A., Gallagher M.J., Ledson M.J., Hart C.A., and Walshaw M.J. Fosfomycin therapy for multiresistant Pseudomonas aeruginosa in cystic fibrosis. J Cyst Fibros 2 (2003) 19-24
7. Zeitlinger M., Marsik C., Steiner I., Sauermann R., Seir K., Jilma B., et al. Immunomodulatory effects of fosfomycin in an endotoxin model in human blood. J Antimicrob Chemother 59 (2007) 219-223